News
Important Only
Soleno Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Soleno Therapeutics Inc SLNO.OQ reported a quarterly adjusted loss of 95 cents per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of -59 cents. The mean expectation of nine analysts for the quarter was for a loss of 93 cents per share. W...Reuters
Wed, May 7
RGC Resources Inc reports results for the quarter ended March 31 - Earnings Summary
RGC Resources Inc RGCO.OQ reported quarterly adjusted earnings of 74 cents per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of 63 cents. The lone analyst forecast for the quarter was for earnings of 68 cents per share. Revenue rose 11...Reuters
Wed, May 7
REFILE-TRADING DAY-Taking the positives from trade, China, Fed
By Jamie McGeever ORLANDO, Florida, May 7 (Reuters) - TRADING DAYMaking sense of the forces driving global marketsBy Jamie McGeever, Markets Columnist Glass half full...probably A late rally ensured Wall Street's three main indexes rose on Wednesday, as investors digested Fed Cha...Reuters
Wed, May 7
OraSure Technologies Inc reports results for the quarter ended March 31 - Earnings Summary
OraSure Technologies Inc OSUR.OQ reported a quarterly adjusted loss of 21 cents per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of -5 cents. The mean expectation of four analysts for the quarter was for a loss of 20 cents per share. W...Reuters
Wed, May 7
Alpha and Omega Semiconductor Ltd reports results for the quarter ended March 31 - Earnings Summary
Alpha and Omega Semiconductor Ltd AOSL.OQ reported a quarterly adjusted loss of 10 cents per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of -4 cents. The mean expectation of three analysts for the quarter was for a loss of 17 cents pe...Reuters
Wed, May 7
Inotiv Inc reports results for the quarter ended March 31 - Earnings Summary
Inotiv Inc NOTV.OQ reported a quarterly adjusted loss of 44 cents per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of $-1.86. The mean expectation of three analysts for the quarter was for a loss of 63 cents per share. Wall Street exp...Reuters
Wed, May 7
Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy
MELBOURNE, Australia and INDIANAPOLIS, May 8, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its Fibroblast Activation Protein (FAP)-targeting therapy candidate, TLX400, has been published in Thyroid, the official journal of the Am...PR Newswire
Wed, May 7
Paycom beats revenue estimate on steady demand for payroll services
May 7 (Reuters) - Payroll processor Paycom Software PAYC.N beat Wall Street estimate for first-quarter revenue on Wednesday, benefiting from steady demand for its employee management services in a robust job market.Cooling inflation and a strong job market are encouraging businesses to hire more peo...Reuters
Wed, May 7
Beyond Meat withdraws annual forecasts as US faux meat demand slides
May 7 (Reuters) - Beyond Meat BYND.O on Wednesday withdrew its annual sales target as macroeconomic volatility and high inflation in the United States added further pressure on faux-meat makers already struggling with weak consumer demand.It had earlier forecast annual net revenue of $320 million to...Reuters
Wed, May 7
Vaxcyte Inc reports results for the quarter ended March 31 - Earnings Summary
Vaxcyte Inc PCVX.OQ reported a quarterly adjusted loss of $1.04 per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of -85 cents. The mean expectation of six analysts for the quarter was for a loss of $1.05 per share. Wall Street expected...Reuters
Wed, May 7
Design Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Design Therapeutics Inc DSGN.OQ reported a quarterly adjusted loss of 31 cents per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of -20 cents. The mean expectation of three analysts for the quarter was for a loss of 28 cents per share. ...Reuters
Wed, May 7
Beyond Meat down after withdrawing annual sales forecast
** Beyond Meat's BYND.O shares fall 5.1% to $2.41 in extended trading** BYND withdraws annual sales target, forecasts Q2 net revenue below estimates** "As the first quarter of 2025 progressed to a close, we saw a slowdown in consumption as the uncertain macroeconomic environment likely exace...Reuters
Wed, May 7
TASER maker Axon raises annual revenue forecast, shares jump
May 7 (Reuters) - TASER maker Axon Enterprise AXON.O raised its full-year revenue forecast on Wednesday, banking on sustained demand for its software products and security devices, sending its shares up more than 7% after the bell.The Arizona-based company makes law enforcement technology such as bo...Reuters
Wed, May 7
CANADA STOCKS-TSX rises to five-week high as tech, financial shares climb
TSX ends up 0.8% at 25,161.18Posts highest closing level since April 2Financials rise 0.7%, tech adds 1.5%Barrick Mining rises after profit beatBy Fergal Smith May 7 (Reuters) - Canada's main stock index rose to a five-week high on Wednesday, led by gains for financial and technology shares, ...Reuters
Wed, May 7
Exagen falls after stock sale launch
** Shares of diagnostic test maker Exagen XGN.O down 16.8% post-market to $5.68 on equity offering news** Vista, California-based co commences stock offering with Canaccord Genuity as sole bookrunner; deal size not disclosed** It intends to use net proceeds for working capital, general purposes, an...Reuters
Wed, May 7
aTyr Pharma Inc reports results for the quarter ended March 31 - Earnings Summary
aTyr Pharma Inc ATYR.OQ reported a quarterly adjusted loss of 17 cents per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -23 cents. The mean expectation of nine analysts for the quarter was for a loss of 19 cents per share. Wall Str...Reuters
Wed, May 7
Why Geron Stock Crept Higher Today
Shares of commercial-stage biotech Geron (NASDAQ: GERN) couldn't quite surmount the hump of Hump Day. After the company released its latest set of quarterly figures, its stock price wobbled as investors determined how best to digest the results. Finally, the stock closed on a downbeat note, booking ...The Motley Fool
Wed, May 7
Vanda Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary
Vanda Pharmaceuticals Inc VNDA.OQ reported a quarterly adjusted loss of 50 cents per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of -7 cents. The mean expectation of three analysts for the quarter was for a loss of 60 cents per share....Reuters
Wed, May 7
ARM down after forecasting quarterly revenue below estimates
** U.S. listed shares of Arm Holdings ARM.O down 8.3% to $114 after the bell** ARM forecasts Q1 sales and profit below Wall Street estimates** Sees Q1 revenue of $1 billion to $1.10 billion, with a midpoint below analysts' average estimate of $1.10 billion, according to data compiled by LSEG** E...Reuters
Wed, May 7
